BRK-B vs DSM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DSM exhibits a stable financial profile with a Piotroski F-Score of 5/9, though it lacks traditional valuation benchmarks like the Altman Z-Score or Graham Number due to its structure as a municipal bond fund. The fund is currently trading at a discount to its book value (P/B of 0.92), which provides a margin of safety, but this is offset by a negative profit margin of -24.23% and stagnant revenue growth. While the dividend yield is sustainable with a low payout ratio, the overall growth trajectory remains muted. The asset is essentially a value play on municipal bond recovery rather than a growth vehicle.
Compare Another Pair
Related Comparisons
BRK-B vs DSM: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and BNY Mellon Strategic Municipal Bond Fund, Inc. (DSM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.